First Time Loading...

Zhejiang CONBA Pharmaceutical Co Ltd
SSE:600572

Watchlist Manager
Zhejiang CONBA Pharmaceutical Co Ltd Logo
Zhejiang CONBA Pharmaceutical Co Ltd
SSE:600572
Watchlist
Price: 4.94 CNY 0.41% Market Closed
Updated: May 2, 2024

Wall Street
Price Targets

Price Targets Summary
Zhejiang CONBA Pharmaceutical Co Ltd

Wall Street analysts forecast Zhejiang CONBA Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang CONBA Pharmaceutical Co Ltd is 5.4 CNY .

Lowest
Price Target
Not Available
Average
Price Target
5.4 CNY
9% Upside
Highest
Price Target
Not Available
Zhejiang CONBA Pharmaceutical Co Ltd Competitors:
Price Targets
GSK
GlaxoSmithKline PLC
10% Upside
GLAND
Gland Pharma Ltd
9% Upside
BOI
Boiron SA
26% Upside
AARTIDRUGS
Aarti Drugs Ltd
12% Upside
ARVN
Arvinas Inc
122% Upside
605116
Aurisco Pharmaceutical Co Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
Zhejiang CONBA Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 16%.

7%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zhejiang CONBA Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's operating income is 2%. The projected CAGR for the next 3 years is 12%.

2%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Zhejiang CONBA Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's net income is -5%. The projected CAGR for the next 3 years is 40%.

-5%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang CONBA Pharmaceutical Co Ltd's stock price target?
Price Target
5.4 CNY

According to Wall Street analysts, the average 1-year price target for Zhejiang CONBA Pharmaceutical Co Ltd is 5.4 CNY .

What is Zhejiang CONBA Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 16%.

What is Zhejiang CONBA Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's operating income is 2%. The projected CAGR for the next 3 years is 12%.

What is Zhejiang CONBA Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
40%

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's net income is -5%. The projected CAGR for the next 3 years is 40%.